Astellas And Sanofi Call For Caution Regarding Similar Sounding Seroquel And Cerocral
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharmaceuticals and Sanofi have issued warnings regarding a possible mix-up of their drugs, Astellas’s schizophrenia drug Seroquel and Sanofi’s Cerocral (sold by Nichi-Iko), for cerebral infarction sequelae and cerebral hemorrhage-related dizziness, as the names appear very similar in Japanese.